ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674178 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674178; 2) Community: the network communities that were significantly associated with the response to NSC 674178; 3) Molecule: the relationships between components within communities and NSC 674178; 4) MDR: the compounds that were significantly associated with the NSC 674178.

NSC Compound Enrichment Correlation
NSC 108165 CP 12252-1 0.0388857481216103 0.2241532
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0388857481216103 0.31274033
NSC 200692 Aspiculamycin hydrochloride 0.0388857481216103 -0.12080501
NSC 630375 2H-1-Benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- 0.0388857481216103 -0.28770938
NSC 631305 cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) 0.0388857481216103 0.36848826
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0388857481216103 0.26743761
NSC 650792 1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- 0.0388857481216103 -0.060314551
NSC 651590 ANTINEOPLASTIC-651590 0.0388857481216103 0.32194118
NSC 680721 5H-1,4,8,11-Benzotetrathiacyclotridecin- 13,14-dicarbonitrile, 2,3,6,7,9,10-hexahydro- 0.0388857481216103 -0.11200306
NSC 681105 Acetic acid, [1,4,7,10-tetraazacyclododecane-1,7-diyl]bis 0.0388857481216103 0.51351474
Total:154  Current:133    [First] [Prev] [Next] [Last]